Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors

Affiliations

¹ Sarah Cannon Research Institute, 93 Harley St, Marylebone, London, W1G 6AD, UK. jinfante@tnonc.com.
² Tennessee Oncology, PLLC, 250 25th Ave North, Nashville, TN, 37203, USA. jinfante@tnonc.com.
³ Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
⁴ California PacificMedical Center (Sutterhealth), 475 Brannan Street, Suite 220, San Francisco, CA, 94107, USA.
⁵ Sarah Cannon Research Institute, 93 Harley St, Marylebone, London, W1G 6AD, UK.
⁶ Tennessee Oncology, PLLC, 250 25th Ave North, Nashville, TN, 37203, USA.
⁷ AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA.
⁸ AstraZeneca, Charter Way, Macclesfield, SK10 2NA, UK.
⁹ Yale Cancer Center, 55 Park Street, Ste First Floor, New Haven, CT, 06519, USA.

Published Erratum

Jeffrey R Infante et al. Invest New Drugs. 2017 Oct.

. 2017 Oct;35(5):669.

doi: 10.1007/s10637-017-0479-3.

¹ Sarah Cannon Research Institute, 93 Harley St, Marylebone, London, W1G 6AD, UK. jinfante@tnonc.com.
² Tennessee Oncology, PLLC, 250 25th Ave North, Nashville, TN, 37203, USA. jinfante@tnonc.com.
³ Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
⁴ California PacificMedical Center (Sutterhealth), 475 Brannan Street, Suite 220, San Francisco, CA, 94107, USA.
⁵ Sarah Cannon Research Institute, 93 Harley St, Marylebone, London, W1G 6AD, UK.
⁶ Tennessee Oncology, PLLC, 250 25th Ave North, Nashville, TN, 37203, USA.
⁷ AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA.
⁸ AstraZeneca, Charter Way, Macclesfield, SK10 2NA, UK.
⁹ Yale Cancer Center, 55 Park Street, Ste First Floor, New Haven, CT, 06519, USA.

No abstract available

Erratum for

A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors.
Infante JR, Cohen RB, Kim KB, Burris HA 3rd, Curt G, Emeribe U, Clemett D, Tomkinson HK, LoRusso PM. Infante JR, et al. Invest New Drugs. 2017 Oct;35(5):576-588. doi: 10.1007/s10637-017-0459-7. Epub 2017 Apr 19. Invest New Drugs. 2017. PMID: 28424891 Free PMC article. Clinical Trial.